Synopsis of recent research by authors named "Suli Dai"
- Suli Dai's recent research focuses on investigating the roles of various long non-coding RNAs (lncRNAs) and small nucleolar RNAs (snoRNAs) in cancer progression, particularly in triple-negative breast cancer, gastric cancer, and esophageal squamous cell carcinoma, exploring their potential as therapeutic targets and biomarkers.
- The findings suggest that KBU2046 impacts cell migration in triple-negative breast cancer by inhibiting TGF-β1 activation, while lncRNA CCAT1 and SNHG5 are implicated in the metabolic reprogramming and progression of gastric and lung cancers, respectively, indicating lncRNAs' significance in cancer biology.
- Additionally, the research highlights the involvement of circRNA-associated ceRNA networks and the regulatory mechanisms of tumor-associated macrophages in tumor microenvironments, emphasizing the interconnected roles of these non-coding RNAs in cancer development and therapy resistance.
